Abstract

BackgroundSchistosoma mansoni cercariae penetrate the skin by releasing excretory/secretory (E/S) products known as 0-3hRP, which are associated with immune modulation through Toll like receptor (TLR) signalling. Furthermore, these secretions contain Sm16, which when given to cells as a recombinant protein inhibits human monocyte derived cytokine responses to TLR4 and TLR3 ligands. Nonetheless, the extent and mechanism(s) of these inhibitory effects remain largely uncharacterized.MethodsMurine bone marrow derived macrophages were exposed to different fractions of 0-3hRP, obtained via ultracentrifugation, or recombinant Sm16. These cells were exposed to the parasite molecules in combination with different TLR ligands, or Interferon gamma, and tested for the production of the cytokines IL-10 and IL-12p40, and their ability to process antigen.ResultsThe immunomodulatory function of 0-3hRP is enriched predominantly in the pellet fraction, which contains a greater proportion of Sm16, also corroborating the ability of recombinant Sm16 to inhibit macrophage activation in response to TLR ligands. We further demonstrate that Sm16 blocks classical activation of macrophages to LPS or IFN-γ stimulation in vitro, and that inhibition of macrophage classical activation is independent of TLR2 recognition. Finally we show that Sm16 shares the altered intracellular processing observed for 0-3hRP, and is able to delay antigen processing by macrophages.ConclusionsCollectively, our findings show that Sm16 is a major component of S. mansoni cercarial E/S products, and is partly responsible for its immune-regulatory properties. Moreover, we propose that the mechanism employed by Sm16 to exert its inhibitory function is likely to be linked with alteration of endosomal trafficking and is not dependent on particular TLR receptors. Finally, we suggest that accumulation of Sm16 in the skin after percutaneous infection with S. mansoni cercariae could contribute to limiting dermal inflammation.Electronic supplementary materialThe online version of this article (doi:10.1186/s13071-014-0608-1) contains supplementary material, which is available to authorized users.

Highlights

  • Schistosoma mansoni cercariae penetrate the skin by releasing excretory/secretory (E/S) products known as 0–3 hour released preparation (0-3hRP), which are associated with immune modulation through Toll like receptor (TLR) signalling

  • Our findings show that Sm16 is a major component of S. mansoni cercarial E/S products, with this protein being partly responsible for the regulatory function of these secretions

  • IL-12p40 production was significantly impaired at 2 μg/ml of 0-3hRPP (p < 0.0001, Figure 1C), whereas the production IL-10 at this dose was not significantly different compared to BMMφs stimulated with LPS only (Figure 1C)

Read more

Summary

Introduction

Schistosoma mansoni cercariae penetrate the skin by releasing excretory/secretory (E/S) products known as 0-3hRP, which are associated with immune modulation through Toll like receptor (TLR) signalling These secretions contain Sm16, which when given to cells as a recombinant protein inhibits human monocyte derived cytokine responses to TLR4 and TLR3 ligands. S. mansoni cercarial E/S products contain more than 50 different proteins [1,6], and are largely released within the first three hours after transformation, this preparation has been termed 0–3 hour released preparation (0-3hRP) [7] These molecules are the first parasite-derived material encountered by innate immune cells (e.g. macrophages, neutrophils, and dendritic cells) in the skin and as such constitute the first line of defense against invading parasites. Sm16 interference with cytokine responses by human monocytes is upstream of IRAK1 activation and NF-κB signalling [10], indicating that it’s functions occur in close association with the earliest events of TLR signal transduction

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call